GS-US-339-1560; A Phase 1b Open-Label Dose Escalation and Expansion Study Evaluating the Safety and Efficacy of Entospletinib (GS-9973) with Vincristine and Dexamethasone in Adult Subjects with Relapsed or Refractory Acute Lymphoid Leukemia (ALL)
-
- STATUS
- Not Recruiting
Summary
This study will evaluate the safety, efficacy, tolerability, and pharmacokinetics of entospletinib (GS-9973) in combination with vincristine (VCR), and dexamethasone in adults with previously treated relapsed or refractory B-cell lineage acute lymphoid leukemia (ALL).
Description
The purpose of this study is to evaluate safety of entosplentinib (GS-9973) in combination with vincristine and dexamethasone in adult subjects with previously treated relapsed or refractory B-cell lineage Acute Lymphoid Leukemia (ALL).
Details
| Condition | acute lymphoid leukemia |
|---|---|
| Age | 18years - 100years |
| Clinical Study Identifier | TX5478 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.